Formulate licensing strategies and negotiate the terms of an agreement
Licensing is a common route for knowledge exchange, but the complexities can make this a slow and painful process. Licensing early-stage technology is often difficult. Universities in particular face unique challenges on the terms they can accept when licensing their IP that industry is not always aware of. This course will give the delegates the tools they need to better structure their licence deals and give them the confidence to negotiate the key terms. Licensing is not just relevant for the ‘big ticket’ tech transfer deals; licence terms are often included in research funding agreements, collaboration agreements, etc.
Develop a licensing strategy (which will include a financial strategy)
Discuss the key issues in a licence agreement and how the principles inter-relate
Understand how to negotiate the terms of a licence agreement
Know how to assess the risks of ‘less than favourable’ terms
Discuss successful and unsuccessful licensing case studies and identify what worked and what could have been improved
2023 Dates are to be announced shortly.
Who should attend?
- Relevant job titles: Relevant to anyone working in KE
- Relevant sectors/organisations: Universities, funding bodies, industry
- Experience needed: 1-3 years’ experience in Technology Transfer, some experience of licensing (run a few smaller deals), a basic understanding on IP is beneficial
- Supporting courses: Fundamentals in Technology Transfer
Paul is a solicitor and a Partner at Anderson Law LLP, a niche firm of commercial/IP solicitors based in Oxfordshire. Paul advises on a wide variety of commercial agreements focussing on transactional work within the IT, life sciences and university sectors. His clients include leading UK universities and an international IT/telecoms company. Paul is listed in Chambers & Partners as a leading UK lawyer in the field of Intellectual Property and is a contributor to a number of Anderson Law’s publications on intellectual property and commercial law, most recently Technology Transfer (3rd Ed, Bloomsbury, 2010).
Dr Andrew Tingey has over 20 years’ experience in a variety of commercial roles centred around licensing and other IP-based transactions, having negotiated a number of high value deals in multiple sectors, including the out-licence of novel gene therapy technologies from the UK’s Gene Therapy Consortium to Boehringer Ingelheim in 2018.
Prior to joining IP Pragmatics, Andrew was Senior Director, Licensing & IP Strategy at Eagle Genomics, a Board Director at Imperial Innovations Ltd., the company that successfully commercialised hundreds of technologies from Imperial College London, and was Director of Licensing at Royal DSM NV, where he led the DSM corporate licensing team based near Maastricht, the Netherlands.
Andrew has held Certified Licensing Professional accreditation since 2012 and also holds a PhD in biochemistry from the University of Leicester, a BSc in biochemistry from the University of York and an MBA from The Open University Business School in the United Kingdom.
Christian is currently Head of Technology Transfer at the University of St Andrews. Christian joined the university in 2019 and has overall responsibility for commercialisation activities, post licence management and the IP portfolio. Christian’s background includes ten years at a firm of IP attorneys and three years working for a semiconductor licensing company in Cambridge.